COVID-19 vaccine, moderna, fda
By Anna Edney Bloomberg News/TNS Moderna Inc.’s vaccine is safe and effective for preventing COVID-19, U.S. regulators said, clearing the way for a second shot to quickly gain emergency authorization and add to the country’s sprawling immunization effort. The Food and Drug Administration’s staff said in a report on Tuesday that the experimental vaccine is 94.1 percent effective at preventing symptomatic COVID-19, confirming earlier results released by the company. The report was posted online ahead of a meeting Thursday of agency advisers who will vote whether to recommend authorizatio...